The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to develop and clinically evaluate 89Zr-labeled HER2-targeted antibodies in diagnosis and screening of HER2-positive cancer patients.
Epistemonikos ID: 32541996e9764e6cd2bca1ec07d57f9c77f5b6a6
First added on: Jun 18, 2025